StockData
CME Group Inc. logo

CME Group Inc. (CME) stock

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 10/3018% above fair value
$311.56−7.81 (-2.45%)

Close on Nov 17, 2026Market cap $111.52BP/E 25.6Yield 1.60%

CME price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CME's price to sales ratio was 16.9× on Nov 11, 2026, against 15.9× a year earlier. Over the last 5 years it ranged from 11.8× to 18.2×, with a median of 14.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202616.9×+1.5
2025Dec 31, 202515.4×+1.6
2024Dec 31, 202413.8×−0.3
2023Dec 29, 202314.2×+2.0
2022Dec 30, 202212.2×−5.5
2021Dec 31, 202117.7×+4.4
2020Dec 31, 202013.3×−1.2
2019Dec 31, 201914.4×−1.7
2018Dec 31, 201816.1×+2.6
2017Dec 29, 201713.6×+2.4
2016Dec 30, 201611.2×+2.1
2015Dec 31, 20159.1×−0.9
2014Dec 31, 201410.1×+1.1
2013Dec 31, 20139.0×+3.4
2012Dec 31, 20125.6×+0.7
2011Dec 30, 20114.9×−2.4
2010Dec 31, 20107.3×−1.1
2009Dec 31, 20098.5×–

More CME figures

See a number that looks wrong?